CN Patent
CN118845797A — 稳定的皮质类固醇组合物
Assigned to Weier Pharmaceutical Biological Preparation Co ltd · Expires 2024-10-29 · 2y expired
What this patent protects
本申请涉及稳定的皮质类固醇组合物。本发明涉及包含皮质类固醇和抗氧化剂的药物组合物。本发明还涉及治疗、预防或缓解胃肠道的炎性疾病和状况的症状以及与胃肠道的炎性疾病和状况相关的炎症的方法,所述方法包括施用包含皮质类固醇和抗氧化剂的药物组合物。
USPTO Abstract
本申请涉及稳定的皮质类固醇组合物。本发明涉及包含皮质类固醇和抗氧化剂的药物组合物。本发明还涉及治疗、预防或缓解胃肠道的炎性疾病和状况的症状以及与胃肠道的炎性疾病和状况相关的炎症的方法,所述方法包括施用包含皮质类固醇和抗氧化剂的药物组合物。
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.